Recombinant human lymphocyte activation gene 3 / LAG3 protein Basic information More..
Product Name:Recombinant human lymphocyte activation gene 3 / LAG3 protein
Synonyms:Recombinant human lymphocyte activation gene 3 / LAG3 protein
CAS:
MF:
MW:0
EINECS:
Mol File:Mol File
Recombinant human lymphocyte activation gene 3 / LAG3 protein
Information Error Report
Your Email:
Browse by province Recombinant human lymphocyte activation gene 3 / LAG3 protein Suppliers Global suppliers
Beijing(1) Jiangsu(1) Member(3) All(3)
Shanghai(1)
Recombinant human lymphocyte activation gene 3 / LAG3 protein Recommend Suppliers
Recommend You Select Member Companies
Company Name: Absin Bioscience Inc.      Recommend    Complaint
Tel: 13761418683
Email: fengmj@univ-bio.com
Products Intro: Product Name:Recombinant Human LAG-3/CD233 (C-Fc)
Package:10ug;50ug;500ug;1mg Remarks: 见爱必信官网  
CB Index: 58
WebSite: www.absin.cn/
Related Information: Sales Network   Catalog(12045)   User Evaluation
Company Name: Suzhou Biodragon Immunotechnologies Co Ltd      Recommend    Complaint
CB Index: 58
WebSite: www.biodragon.cn
Related Information: Sales Network   Catalog(6583)   User Evaluation
Company Name: Rockland Immunochemicals Inc      Recommend    Complaint
CB Index: 58
WebSite: www.antibodies-online.cn
Related Information: Sales Network   Catalog(6808)   User Evaluation
1
Tag: Recombinant human lymphocyte activation gene 3 / LAG3 protein
  • HomePage | About Us | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.